AFT's growth story appears to be intact, despite it disappointing investors previously.
AFT Pharmaceuticals' net profit fell to $7.8 million for the year ended March from $12.7m.
In search of a clean bill of health, Henry Burrell trials the next generation in preventative healthcare technology.
The recently rebranded healthcare provider is ploughing ahead with its migration to cloud services.